← Back to Screener
Adlai Nortye Ltd. American Depositary Shares (ANL)
Price$13.69
Favorite Metrics
Price vs S&P 500 (26W)661.91%
Price vs S&P 500 (4W)72.99%
Market Capitalization$627.20M
All Metrics
Book Value / Share (Quarterly)$0.07
P/TBV (Annual)3.89x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.47
Price vs S&P 500 (YTD)830.46%
EPS (TTM)$-0.73
10-Day Avg Trading Volume0.74M
EPS Excl Extra (TTM)$-0.73
EPS (Annual)$-0.54
ROI (Annual)-98.40%
Cash / Share (Quarterly)$0.40
ROA (Last FY)-72.78%
EBITD / Share (TTM)$-0.70
Cash Flow / Share (Annual)$-0.47
P/B Ratio79.18x
P/B Ratio (Quarterly)6.85x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-25.63x
ROA (TTM)-97.97%
EPS Incl Extra (Annual)$-0.54
Current Ratio (Annual)1.41x
Quick Ratio (Quarterly)0.98x
3-Month Avg Trading Volume0.75M
52-Week Price Return538.55%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.07
P/S Ratio (Annual)125.44x
Asset Turnover (Annual)0.04x
52-Week High$15.79
EPS Excl Extra (Annual)$-0.54
26-Week Price Return665.90%
Quick Ratio (Annual)1.37x
13-Week Price Return733.33%
Total Debt / Equity (Annual)1.07x
Current Ratio (Quarterly)1.03x
Enterprise Value$627.633
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2184.56%
Cash / Share (Annual)$0.55
3-Month Return Std Dev245.92%
Net Income / Employee (TTM)$-1
ROE (Last FY)-203.53%
Net Interest Coverage (Annual)-26.32x
EPS Basic Excl Extra (Annual)$-0.54
P/FCF (TTM)23.76x
Total Debt / Equity (Quarterly)5.63x
EPS Incl Extra (TTM)$-0.73
ROI (TTM)-133.47%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.23
Price vs S&P 500 (52W)508.72%
Year-to-Date Return833.10%
5-Day Price Return10.42%
EPS Normalized (Annual)$-0.54
ROA (5Y Avg)-90.58%
Net Profit Margin (Annual)-2184.56%
Month-to-Date Return91.47%
Cash Flow / Share (TTM)$-1.65
EBITD / Share (Annual)$-0.50
Operating Margin (Annual)-1451.02%
EPS Basic Excl Extra (TTM)$-0.73
P/TBV (Quarterly)6.87x
P/B Ratio (Annual)3.89x
Book Value / Share (Annual)$0.23
Price vs S&P 500 (13W)732.65%
Beta0.83x
Revenue / Share (TTM)$0.00
ROE (TTM)-420.31%
52-Week Low$0.88
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ANLAdlai Nortye Ltd. American Depositary Shares | — | — | — | — | $13.69 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Adlai Nortye Ltd is a clinical-stage biotech company developing cancer therapies targeting multiple tumor types. The company's pipeline comprises three clinical-stage drug candidates and three preclinical assets.